Volume: 9 Issue: 2
Year: 2021, Page: 58-62, Doi: https://doi.org/10.47799/pimr.0902.13
Received: Dec. 20, 2020 Accepted: Jan. 10, 2021 Published: Jan. 10, 2021
Background: Heart failure in women associated with pregnancy and the peripartum period is now recognized as a distinctive form of cardiomyopathy. Its prevalence and mortality vary in different geographical locations. There is a paucity of data from our group of the population regarding peripartum cardiomyopathy hence we conducted the study to determine the incidence, aetiology of PPCM in our study group along with treatment and maternal outcomes.
Methods: Patients with any parity and age, which are in their peripartum period i.e. one month before delivery or within five months of delivery. Patients presenting with moderate to severe breathlessness at rest or on exertion with palpitations, ankle oedema, or with signs and symptoms of heart failure. Documented systolic dysfunction with the echocardiographic finding of Ejection fraction of <45% and or Fractional shortening <30%, absence of another identifiable cause for the HF.
Results: Overall incidence of PPCM in our institution is 9 per 1000 deliveries. Among n=67 PPCM cases, n=26 patients (38.80%) developed PPCM during pregnancy and n=41 patients (61.2%) during postpartum period. The majority of the patients n=49 cases (73.13%) had severe left ventricular systolic dysfunction (EF =30%) and n=10 (14.92%) had moderate left ventricular systolic dysfunction and n=8 had mild LV dysfunction. There was no significant statistical difference in the severity of LV dysfunction between primi and multiparous women.
Conclusion: The main factors are advanced maternal age and multiparity. Twin pregnancies are also risk factors for the development of PPCM. Yet another important risk factor was Pre-eclampsia. There is no single explanation for the pathogenesis of PPCM that is relevant for all women. Recognition of symptoms of breathlessness, orthopnea, and pedal edema in the post-partum period with a history of preeclampsia should arouse a high degree of suspicion.
Keywords: Peripartum Cardiomyopathy [PPCM], Incidence, Heart failure, cardiomyopathy
1. Ritchie C. Clinical contributions to the pathology, diagnosis, and treatment of certain chronic diseases of the heart. John Stark; 1850.
2. Gouley BA. Idiopathic myocardial degeneration associated with pregnancy and especially the peripartum. Am J Med Sci. 1937;19:185-99.
3. Liwa K, Mebazaa A, Hilfiker-Kleiner D, Petrie MC, Maggioni AP, et al. Clinical characteristics of patients from the worldwide registry on peripartum cardiomyopathy (PPCM) EURObservational Research Program in conjunction with the Heart Failure Association of the European Society of Cardiology Study Group on PPCM. European journal of heart failure. 2017;19(9):1131-41.
4. Sliwa, K., Hilfiker-Kleiner, D Petrie, M.C., Mebazaa, A., et al. Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathy. European journal of heart failure 2010;12(8):767-78.
5. Pearson GD, Veille JC, Rahimtoola S, Hsia J, Oakley CM, Hosenpud JD, Ansari A, Baughman KL. Peripartum cardiomyopathy: national heart, lung, and blood institute and office of rare diseases (national institutes of health) workshop recommendations and review. Jama. 2000 Mar 1;283(9):1183-88.
6. Seftel H, Susser M. Maternity and myocardial failure in African women. Br Heart J 1961; 23:43.
7. Davidson NM, Parry EH. The etiology of peripartum cardiac failure. Am Heart J 1979; 97:535.
8. Woolford RM. Postpartum myocardosis. Ohio State Med J 1952; 48:924.
9. Pierce JA, Price BO, Joyce JW. Familial occurrence of postpartal heart failure. Arch Intern Med 1963; 111:651.
10. Sliwa K, Damasceno A, Mayosi BM. Epidemiology and etiology of cardiomyopathy in Africa. Circulation 2005; 112:3577.
11. Pandit V, Shetty S, Kumar A, Sagir A. Incidence and outcome of peripartum cardiomyopathy from a tertiary hospital in South India. Tropical doctor. 2009;39(3):168- 69.
12. Aditi V. Joshi, Michelle N. Fonseca, Deepali S. KharatKapote. A study of peripartum cardiomyopathy in a tertiary care center in India. Int J Reprod Contracept Obstet Gynecol. 2017 Feb;6(2):523-526.
13. Fett JD, Christie LG, Carraway RD, Murphy JG. Five-year prospective study of the incidence and prognosis of peripartum cardiomyopathy at a single institution. Mayo Clin Proc 2005; 80:1602.
14. Mielniczuk LM, Williams K, Davis DR, et al. Frequency of peripartum cardiomyopathy.Am J Cardiol 2006;97:1765– 68.
15. Lee S, Cho GJ, Park GU, Kim LY, Lee TS, Kim DY, Choi SW, Young JC, Han SW, Ryu KH, NaJO. Incidence, risk factors, and clinical characteristics of peripartum cardiomyopathy in SouthKorea. Circulation: Heart Failure. 2018;11(4):e004134.
16. Chee KH, Azman W. Prevalence and outcome of peripartum cardiomyopathy in Malaysia. Int J Clin Pract 2009;63:722–25.
17. Laghari, A.H., Khan, A.H. Kazmi, K.A. Peripartum cardiomyopathy: ten-year experience at a tertiary care hospital in Pakistan. BMC Research Notes 2013; 6:495.
18. Lampert MB, Lang RM. Peripartum cardiomyopathy. Am Heart J 1995; 130:860.
19. Desai D, Moodley J, Naidoo D. Peripartum cardiomyopathy: experiences at King Edward VIII Hospital, Durban, South Africa and a review of the literature. Trop Doct 1995;25:118.
20. Karaye KM, Sani MU. Factors associated with poor prognosis among patients admitted with heart failure in a Nigerian tertiary medical centre: a cross-sectional study. BMC Cardiovasc Disord 2008;8(1):16.
21. Elkayam U, Akhter MW, Singh H, et al. Pregnancyassociated cardiomyopathy: clinicalcharacteristics and a comparison between early and late presentation. Circulation 2005; 111:2050.
22. Bello N, Rendon IS, Arany Z. The relationship between pre-eclampsia and peripartum cardiomyopathy: A systematic review and meta-analysis. J Am Coll Cardiol 2013; 62:1715-23
23. Chapa JB, Heiberger HB, Weinert L, et al. Prognostic value of echocardiography in peripartum cardiomyopathy. ObstetGynecol 2005; 105:1303-08.
24. Mahmood Ul Hassan, Bakhatawar Shah, Bushra Rauf, Cheragh Hussain.Peripartum Cardiomyopathy - An InHospital Study. Pak Heart J 2019;52(3):219-223.
25. Goland S, Modi K, Bitar F, et al. Clinical profile and predictors of complications in peripartum cardiomyopathy. J Card Fail 2009; 15:645-50.
26. Sliwa K, Fett J, Elkayam U. Peripartum cardiomyopathy. Lancet 2006;368:68793.
27. Elkayam U. Clinical characteristics of peripartum cardiomyopathy in the United States:diagnosis, prognosis, and management. J Am Coll Cardiol 2011; 58:659-63.
Kanaparthi S, Jana S, Kasturi RR, Mudgalkar N. A Study of Incidence and outcome of Peripartum Cardiomyopathy in a Tertiary Care Teaching Hospital. Perspectives in Medical Research 2021; 9 (2):58-62 DOI:10.47799/pimr.0902.13